Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Cancer Research UK
Sponsor:
Information provided by (Responsible Party):
Cancer Research UK
ClinicalTrials.gov Identifier:
NCT01390571
First received: July 7, 2011
Last updated: August 25, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)